Reduction of excessive unfolded protein response by 4-phenylbutyric acid may mitigate procymidone-induced testicular damage in mice by changing the levels of circRNA Scar and circZc3h4.

Pestic Biochem Physiol

Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Medical School, Hunan Normal University, Changsha 410013, China; Department of Preventive Medicine, Medical School, Hunan Normal University, Changsha 410013, China. Electronic address:

Published: December 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Procymidone (PCM) exposure below the no-observed-effect level triggers changes in circRNA Scar and circZc3h4 and overactivation of the unfolded protein response (UPR) in mice, culminating in testicular injury. The 4-phenyl butyric acid (4-PBA) is known to stabilize proteins and reduce the UPR. This study employed an in vitro system in which mouse testes were cultured with 1 × 10 M PCM and varying concentrations (0, 20, 40, and 80 mM) of 4-PBA; 4-week-old male mice were subsequently treated with 100 mg/kg/d PCM (suspended in corn oil) and/or 100 mg/kg/d 4-PBA for 21 d, consecutively. The treatments were as follows: the negative control (NC) group was orally administered corn oil; the positive control (PC) group was orally administered PCM; the 4-PBA group was intraperitoneally injected with 4-PBA; the 4-PBA-I group was orally administered PCM and 4-PBA simultaneously; the 4-PBA-II group received daily administration of 4-PBA 24 h prior to PCM; and the 4-PBA-III group was intraperitoneally injected with 4-PBA for 7 d after 21 d of PCM administration. However, the 4-PBA intervention groups showed no considerable changes in the overall or testicular appearance of mice. In vitro, 4-PBA inhibited the PCM-induced testicular injury, with the most significant effect observed at 80 mM. In vivo, the 4-PBA-III group exhibited the best in vivo effects. Our findings indicate that 4-PBA conferred testicular protection by decreasing PCM-induced circRNA Scar, elevating circZc3h4, and suppressing UPR both in vitro and in vivo. It has been hypothesized that 4-PBA mitigates testicular damage by reducing excessive UPR levels.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pestbp.2023.105689DOI Listing

Publication Analysis

Top Keywords

circrna scar
12
4-pba
12
group orally
12
orally administered
12
unfolded protein
8
protein response
8
testicular damage
8
scar circzc3h4
8
testicular injury
8
corn oil
8

Similar Publications

Mechanistic insights into circularization via group I intron-based scarless circular RNA.

Mol Ther Nucleic Acids

September 2025

MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian 116024, China.

Circular RNA (circRNA) offers significant advantages in stability, storage, manufacturing, and pharmacokinetics, making it an attractive option for therapeutic applications over linear RNA. However, the commonly used permuted intron-exon (PIE) method for constructing circRNA introduces an exogenous "scar" sequence during splicing initiation, potentially compromising circRNA potency and inducing immunogenicity. Through exploration of the molecular mechanism of the group I intron splicing, we conclude the sequence characterization of splice sites and the recognition rules of IG sequence.

View Article and Find Full Text PDF

Development and comprehensive evaluation of scarless circularization systems for circular RNA therapeutics.

Mol Ther Nucleic Acids

September 2025

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.

Circular RNAs (circRNAs) are promising candidates for RNA-based therapeutics due to their enhanced stability and sustained protein production compared to linear mRNAs. Traditional circRNA production methods, such as the Anabaena-based permuted intron-exon (Ana-PIE) system, often introduce extraneous sequences, referred to as "scars." However, a comprehensive evaluation of the functional consequences of incorporating or omitting extraneous "scar" sequences during circRNA production is lacking.

View Article and Find Full Text PDF

The treatment of complex wounds presents a significant clinical challenge due to the limited availability of standardized therapeutic options. Adipose-derived stem cell exosomes (ADSC-Exos) are promising for their capabilities to enhance angiogenesis, mitigate oxidative stress, modulate inflammatory pathways, support skin cell regeneration, and promote epithelialization. These exosomes deliver non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, which facilitate collagen remodeling, reduce scar formation, and expedite wound healing.

View Article and Find Full Text PDF

Collaborative Duality of CircGLIS3(2) RNA and Protein in human Wound Repair.

Adv Sci (Weinh)

July 2025

Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, 17176, Sweden.

The discovery of an increasing number of translatable circular RNAs (circRNAs) raises the question of whether their coding and non-coding functions can coexist within the same cell. This study profiles the dynamic expression of circRNAs during human skin wound healing. CircGLIS3(2) is identified, a circRNA whose levels transiently rise in dermal fibroblasts of acute wounds and are abnormally overexpressed in keloids, a fibrotic skin condition.

View Article and Find Full Text PDF

Peptide nucleic acid-mediated circularization of target RNA as tool to inhibit translation.

Int J Biol Macromol

May 2025

Ceinge-Biotecnologie Avanzate S.c.a.r.l., Via Gaetano Salvatore 486, 80145 Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy; ImGen-T Srl, Viale del Parco Carelli, Napoli, NA, Italy. Electronic address: ema

Antisense oligonucleotides (ASOs) are short, synthetic sequences designed to specifically target RNA target molecules to modulate their translation and protein expression. To enhance their stability, chemically modified ASOs have been developed. Over the decades, peptide nucleic acids (PNAs) have emerged as powerful tools in molecular biology, proving their ability in gene knockdown, as well as therapeutic or diagnostic applications.

View Article and Find Full Text PDF